Cord Blood T Cells Show Antitumor Effects in Mice
Author Information
Author(s): Lee Yong-Soo, Kim Tae-Sik, Kim Dong-Ku
Primary Institution: Samsung Biomedical Research Institute, CHA University, National Cancer Center Research Institute, Konkuk University
Hypothesis
Can T lymphocytes derived from human cord blood provide effective antitumor immunotherapy against human tumors?
Conclusion
Cord blood derived T lymphocytes exhibit significant antitumor effects in a mouse model of cervical and lung cancer.
Supporting Evidence
- CB-T cells showed significant infiltration into tumors and induced tumor cell death.
- Complete tumor remission was observed in mice receiving CB mononuclear cells.
- CD3+ T cells from cord blood exhibited high cytotoxicity against tumor cells.
Takeaway
Scientists found that T cells from umbilical cord blood can help fight tumors in mice, making them a promising option for cancer treatment.
Methodology
The study used NOD/SCID mice to test the effects of cord blood mononuclear cells on tumor growth, measuring tumor size and weight.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
NOD/SCID mice were used as the model organism.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website